Topical Products

Using SkyePharma's proprietary drug delivery technologies, SkyePharma develops new formulations of approved pharmaceutical products as well as products incorporating new chemical entities to provide a clinical benefit to patients.

There is one approved product in the area of topical drug delivery (Solaraze) that incorporates SkyePharma’s proven proprietary technologies. SkyePharma’s products are marketed in a number of countries throughout the world by leading and speciality pharmaceutical companies.

SkyePharma has out-licensed its topical technologies as it is focussing on oral and inhalation technologies.

For enquiries, please
contact us.

SkyePharma PLC is a public limited company registered in England and Wales, registration number 0107582.
Registered office: 46-48 Grosvenor Gardens, London SW1W 0EB, United Kingdom